Titus M. F. M. Plattel
Keine laufenden Positionen mehr
Profil
Titus M.
F.
M.
Plattel formerly worked at Biogen MA, Inc., as Director-International Marketing in 2004, Amgen Boulder, Inc., as Head-Sales, Tolerx, Inc., as Vice President-Marketing & Commercial Strategy from 2008 to 2011, and Therion Biologics Corp., as Vice President-Marketing in 2006.
Mr. Plattel received his Masters Business Admin degree from Pepperdine University and graduate degree from Radboud University Nijmegen.
Ehemalige bekannte Positionen von Titus M. F. M. Plattel
| Unternehmen | Position | Ende |
|---|---|---|
Tolerx, Inc.
 Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | Vertrieb & Marketing | 19.12.2011 |
Therion Biologics Corp.
 Therion Biologics Corp. Pharmaceuticals: MajorHealth Technology Therion Biologics Corp. developed therapeutic vaccines for cancer patients. The company was founded on May 5, 1991 and was headquartered in Cambridge, MA. | Vertrieb & Marketing | 01.09.2006 |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Vertrieb & Marketing | 01.07.2004 |
Amgen Boulder, Inc.
 Amgen Boulder, Inc. Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Amgen Boulder, Inc. discovers, develops, and produces protein-based human pharmaceuticals. The company is based in Longmont, CO. | Vertrieb & Marketing | - |
Ausbildung von Titus M. F. M. Plattel
| Pepperdine University | Masters Business Admin |
| Radboud University Nijmegen | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | Health Technology |
Amgen Boulder, Inc.
Amgen Boulder, Inc. Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Amgen Boulder, Inc. discovers, develops, and produces protein-based human pharmaceuticals. The company is based in Longmont, CO. | Health Technology |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Therion Biologics Corp.
Therion Biologics Corp. Pharmaceuticals: MajorHealth Technology Therion Biologics Corp. developed therapeutic vaccines for cancer patients. The company was founded on May 5, 1991 and was headquartered in Cambridge, MA. | Health Technology |
